8-K current report · filed Aug 4, 2026

ORTHOPEDIATRICS CORP (KIDS) 8-K Current Report: August 4, 2026

Item 2.02Item EX-99.1KIDS overview

Short answer

ORTHOPEDIATRICS CORP (KIDS) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 earnings release announced for quarter ended June 30, 2026.

ORTHOPEDIATRICS CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 2026 earnings release announced for quarter ended June 30, 2026
  • Unaudited condensed consolidated financial statements and supporting financial data available in Exhibit 99.1
  • Investor focus: quarterly revenue, profitability, cash flow, and guidance details in the accompanying release

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $70.5M, up 15%, with Trauma and Deformity growth 26% offsetting Scoliosis decline of 9%
  • Adjusted EBITDA rose to $6.8M from $4.1M, while gross margin expanded to 74% from 72%
  • Free cash flow use improved 78% to $3.1M, supporting management’s target for full-year 2026 cash-flow breakeven
  • 2026 revenue guidance increased to $265.0M-$269.0M, with adjusted EBITDA guidance approximately $25.0M
  • Liquidity declined to $47.9M from $62.9M at December 31, 2025, while Q2 net loss remained $7.2M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ORTHOPEDIATRICS CORP 8-K filings

Get the next KIDS 8-K as it lands

Follow KIDS for push alerts, or ask the research agent what this filing means.